Trial Profile
Phase I trial of Bevacizumab and S-1 chemotherapy for patients with previously treated advanced non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Feb 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 10 Feb 2021 Status changed from recruiting to completed.
- 07 Aug 2012 New trial record